Trial Profile
A Pivotal, Phase 1, Open-Label, Randomized, Crossover, Single-Dose, Comparative Bioavailability Study of Buprenorphine-Naloxone Sublingual Spray and Suboxone Sublingual Film in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Buprenorphine/naloxone (Primary) ; Buprenorphine/naloxone
- Indications Opioid-related disorders
- Focus Pharmacokinetics
- Sponsors INSYS Pharma
- 02 Sep 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 Jun 2015 New trial record